首页 | 本学科首页   官方微博 | 高级检索  
     

R-CHOP方案治疗老年弥漫大B细胞淋巴瘤患者疗效分析
引用本文:朱志刚,李康保,许昕,张彩萍,孙启鑫,钟伟杰,朱国栋,孟凡义. R-CHOP方案治疗老年弥漫大B细胞淋巴瘤患者疗效分析[J]. 内科急危重症杂志, 2011, 17(6): 351-352
作者姓名:朱志刚  李康保  许昕  张彩萍  孙启鑫  钟伟杰  朱国栋  孟凡义
作者单位:1. 南方医科大学南方医院 广州 510180
2. 广州市第一人民医院
摘    要:目的:评价R-CHOP方案治疗老年弥漫大B细胞淋巴瘤(DLBCL)患者的疗效及不良反应.方法:观察25例70~86岁DLBCL患者,用R-CHOP方案治疗8疗程,之后用美罗华单药维持(每3个月1次,维持2年);分析化疗的疗效及不良反应.结果:19例达到完全缓解(CR),6例达到部分缓解(PR),无严重的不良反应.12例...

关 键 词:老年  弥漫大B细胞淋巴瘤  联合化疗

Analysis of Therapeutic Effect of Rituximab in Combination With CHOP for Elderly Patients With Diffuse Large B-Cell Lymphoma
ZHU Zhigang,LI Kangbao,XU Xin,et al.. Analysis of Therapeutic Effect of Rituximab in Combination With CHOP for Elderly Patients With Diffuse Large B-Cell Lymphoma[J]. Journal of Internal Intensive Medicine, 2011, 17(6): 351-352
Authors:ZHU Zhigang  LI Kangbao  XU Xin  et al.
Affiliation:ZHU Zhigang,LI Kangbao,XU Xin,et al. The NanFang hospital of Southern Medical University,Gnangzhou510180,China
Abstract:Objective: To evaluate the therapeutic effect and adverse reaction of rituximab in combination with CHOP ( R-CHOP) for the elderly patients with diffuse large B-cell lymphoma ( DLBCL) . Methods: Twenty-five elderly patients aged 75 ~ 80 with DLBCL were observed. Eight cycles of R-CHOP had been taken for every patients and maintenance therapy of single dose Mabthera had been used every 3 months and lasted for 2 years. The therapeutic effect and adverse reaction were analyzed. Results: Nineteen cases achieved complete remission ( CR) and 6 cases achieved partial remission ( PR) ,no serious adverse reaction had been observed. Twelve patients who had completed maintenance therapy of Mabthera for 2 years showed no recurrence in the follow-up. Conclusion: Combination of Mabthera with chemotherapy are well tolerated by elderly patients with DLBCL and without serious adverse reaction.
Keywords:The aged Diffuse large B-cell lymphoma Chemotherapy  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号